147 related articles for article (PubMed ID: 2297727)
1. 99mTc labeling of proteins: initial evaluation of a novel diaminedithiol bifunctional chelating agent.
Baidoo KE; Scheffel U; Lever SZ
Cancer Res; 1990 Feb; 50(3 Suppl):799s-803s. PubMed ID: 2297727
[TBL] [Abstract][Full Text] [Related]
2. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
3. Optimum conditions for labeling of DTPA-coupled antibodies with technetium-99m.
Childs RL; Hnatowich DJ
J Nucl Med; 1985 Mar; 26(3):293-9. PubMed ID: 3882905
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-labeled monoclonal antibody with preserved immunoreactivity and high in vivo stability.
Arano Y; Yokoyama A; Furukawa T; Horiuchi K; Yahata T; Saji H; Sakahara H; Nakashima T; Koizumi M; Endo K
J Nucl Med; 1987 Jun; 28(6):1027-33. PubMed ID: 3585492
[TBL] [Abstract][Full Text] [Related]
5. Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.
Deshpande SV; DeNardo SJ; Kukis DL; Moi MK; McCall MJ; DeNardo GL; Meares CF
J Nucl Med; 1990 Apr; 31(4):473-9. PubMed ID: 2324823
[TBL] [Abstract][Full Text] [Related]
6. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.
Karra SR; Schibli R; Gali H; Katti KV; Hoffman TJ; Higginbotham C; Sieckman GL; Volkert WA
Bioconjug Chem; 1999; 10(2):254-60. PubMed ID: 10077475
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-neolactosylated human serum albumin for imaging the hepatic asialoglycoprotein receptor.
Jeong JM; Hong MK; Lee J; Son M; So Y; Lee DS; Chung JK; Lee MC
Bioconjug Chem; 2004; 15(4):850-5. PubMed ID: 15264873
[TBL] [Abstract][Full Text] [Related]
11. Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.
Kozak RW; Raubitschek A; Mirzadeh S; Brechbiel MW; Junghans RP; Gansow OA; Waldmann TA
Cancer Res; 1989 May; 49(10):2639-44. PubMed ID: 2785435
[TBL] [Abstract][Full Text] [Related]
12. Reduction-mediated technetium-99m labeling of monoclonal antibodies.
Mather SJ; Ellison D
J Nucl Med; 1990 May; 31(5):692-7. PubMed ID: 2341907
[TBL] [Abstract][Full Text] [Related]
13. Development of radiochemically pure antibodies.
Eckelman WC
Cancer Res; 1990 Feb; 50(3 Suppl):780s-782s. PubMed ID: 2297723
[TBL] [Abstract][Full Text] [Related]
14. Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate).
Kasina S; Sanderson JA; Fitzner JN; Srinivasan A; Rao TN; Hobson LJ; Reno JM; Axworthy DB; Beaumier PL; Fritzberg AR
Bioconjug Chem; 1998; 9(1):108-17. PubMed ID: 9460553
[TBL] [Abstract][Full Text] [Related]
15. Preparation and properties of antitumor monoclonal antibodies labeled with metallic radionuclides indium-111, gallium-67, and technetium-99m.
Endo K; Sakahara H; Nakashima T; Koizumi M; Ohta H; Kawamura Y; Kunimatsu M; Furukawa T; Ohmomo Y; Arano Y
NCI Monogr; 1987; (3):135-40. PubMed ID: 3469526
[TBL] [Abstract][Full Text] [Related]
16. Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent.
Kasina S; Rao TN; Srinivasan A; Sanderson JA; Fitzner JN; Reno JM; Beaumier PL; Fritzberg AR
J Nucl Med; 1991 Jul; 32(7):1445-51. PubMed ID: 2066805
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m labeling of DNA oligonucleotides.
Hnatowich DJ; Winnard P; Virzi F; Fogarasi M; Sano T; Smith CL; Cantor CR; Rusckowski M
J Nucl Med; 1995 Dec; 36(12):2306-14. PubMed ID: 8523124
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues.
Baidoo KE; Lin KS; Zhan Y; Finley P; Scheffel U; Wagner HN
Bioconjug Chem; 1998; 9(2):218-25. PubMed ID: 9548537
[TBL] [Abstract][Full Text] [Related]
19. [Labeling of unnatural amino acids with 99mTc and tissue distribution of the labeled products in mice].
Tamemasa O; Goto R; Takeda A
Radioisotopes; 1981 Dec; 30(12):674-8. PubMed ID: 7335909
[TBL] [Abstract][Full Text] [Related]
20. High-affinity no-carrier-added 99mTc-labeled chemotactic peptides for studies of inflammation in vivo.
Baidoo KE; Scheffel U; Stathis M; Finley P; Lever SZ; Zhan Y; Wagner HN
Bioconjug Chem; 1998; 9(2):208-17. PubMed ID: 9548536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
